cyc 202 has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boussiotis, V; Kim, Js; Li, L; Pihan, G; Wang, H | 1 |
Grant, S | 1 |
2 other study(ies) available for cyc 202 and Graft vs Host Disease
Article | Year |
---|---|
The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD.
Topics: Acute Disease; Animals; Cell Cycle; Cell Line; Cyclin-Dependent Kinase 2; Female; Graft vs Host Disease; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; Protein Kinase Inhibitors; Purines; Roscovitine; Signal Transduction; Smad3 Protein; Survival Rate; T-Lymphocytes; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2009 |
CDK inhibitors and immune responses.
Topics: Animals; Cell Line; Cyclin-Dependent Kinases; Female; Graft vs Host Disease; Mice; Models, Animal; Protein Kinase Inhibitors; Purines; Roscovitine; Signal Transduction; T-Lymphocytes | 2009 |